| Literature DB >> 31572808 |
Natalia Mazur-Panasiuk1, Jacek Żmudzki1, Grzegorz Woźniakowski1.
Abstract
Since 2007, African swine fever (ASF) has posed a serious threat to the European swine industry. In Poland, the numbers of reported outbreaks in pigs and affected areas grow every year. In 2018, the disease was noted in Western Europe, in Belgium specifically, where several hundred infected wild boars have been detected so far. In 2018, the virus unexpectedly emerged in pig holdings in eastern China, northern Mongolia, Vietnam, and Cambodia, causing worldwide concern about its further spread. Since there is still no vaccine available, the only approach to control the disease is biosecurity. Identification of potential sources of the virus is extremely important in light of its phenomenal survivability. The review summarises the current knowledge about ASFV survivability and resistance to environmental conditions, and discusses the role of indirect contact in spreading the disease.Entities:
Keywords: ASFV; indirect transmission; spreading; stability; survivability
Year: 2019 PMID: 31572808 PMCID: PMC6749736 DOI: 10.2478/jvetres-2019-0058
Source DB: PubMed Journal: J Vet Res ISSN: 2450-7393 Impact factor: 1.744
Current Eurasian ASFV strain levels of maximum viraemia in blood and shedding potential in other body fluids after various modes of inoculation
| Maximum viraemia | ||||||
|---|---|---|---|---|---|---|
| Inoculation mode | ASFV strain | Dose HAD50/(mL) | Titre (log10 HAD50/mL) | Dpi | Virus detection in other body secretions/excretions | Reference |
| Georgia 2007/1 | 102 | 6–8 | 5 | Nasal fluid: VI+ (102–104), 5 dpi Rectal fluid: (10–102), 6 dpi Urine: Excretions: PCR+*, PCR+*, VI+ VI+ Oral fluid: PCR+*, VI− *1st day of fever | Guinat | |
| Intramuscular | Lithuania LT14/1490 | 101 | 6.4–8.7 | 6 | n/a | Gallardo |
| 5 × 103 | 6.5–7 | 7 | Nasal fluid: PCR+ | |||
| Russia K/08/13 | 50 | 6.5–7 | 9 | Rectal fluid: PCR+ | Vlasova | |
| Georgia 2007/1 | 103 | 7–8 | 7 | n/a | O’Donnell | |
| Odintsovo 02/14 | 5 × 103 | 7.56 | 11 | n/a | Elsukova | |
| Caucasian | 2 × 106 | Cq: 22–39 | 5 | Oropharyngeal Faecal fluid: PCR+, fluid: 5 PCR+, dpi 6 dpi | Blome | |
| 5 × 103 | 7.5 | 7 | ||||
| Kashino 04/13 | 50 | 6.5–7.5 | 7 | Nasal fluid: PCR+ | ||
| 5 × 103 | 6.5–7.5 | 9 | Rectal fluid: PCR+ | Vlasova | ||
| Boguchary 06/13 | 50 | 6.5–7 | 5 | |||
| Oral/nasal | Pol/15/Lindholm | 2 × 104 | ~9 | 6 | Nasal fluid: PCR+*, VI+ (101.6–4.8) Rectal fluid: PCR+*, VI+ (102.8–3) Oral fluid: PCR +*, VI− *1st day of fever Viral isolation at day of euthanasia | Olesen |
| Odintsovo 02/14 | 103 | 7.45 | 11 | n/a | Elsukova | |
| 50 | 7.45 | 27 | ||||
| Caucasian | n/a | Cq: 20–29 | 11 | n/a | Blome | |
| Georgia 2007/1 | n/a | 6–8 | 10 | Nasal rectal fluid: fluid: VI+ VI+ ((1010––101022) ) from from 7 12 dpi, dpi | Guinat | |
| Kashino 04/13 | n/a | 6.5–7 | 15 | n/a | ||
| Boguchary 06/13 | n/a | 7 | 9 | n/a | Vlasova | |
| Contact | Lithuania LT14/1490 | n/a | 6.4–8.7 | 14 | n/a | Gallardo |
| Odintsovo 02/14 | n/a | 7.45–7.66 | 29 | n/a | Elsukova | |
| Pol/15/Lindholm | n/a | ~9 | 12 | Nasal fluid: PCR+, VI+ (101.8–2.8) Rectal fluid: PCR+, VI+ (101.6–8) Oral fluid: VI− PCR + in many prior to the PCR+ from blood | Olesen | |
n/a – not applicable, dpi – day post infection, HAD50/mL – haemadsorbing doses per millilitre, PCR+(−) – viral DNA detected (not detected) by real-time PCR, VI+(−) – infectious virus detected (not detected) by virus isolation in cell culture